Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT02017535

An Adaptive Treatment Strategy for Adolescent Depression-Continuation (PTAD GIA)

A Personalized Approach to Achieving a Sustained Response to Treatment for Adolescent Depression

Sponsor: University of Minnesota

Interventions Fluoxetine Interpersonal Psychotherapy

Updated 10 times since 2017 Last updated: Mar 9, 2020 Started: Jun 30, 2012 Primary completion: Oct 1, 2018 Completion: Oct 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02017535, this PHASE1/PHASE2 trial focuses on Adolescent Depression and remains completed. Sponsored by University of Minnesota, it has been updated 10 times since 2012, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Apr 2020 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Dec 2019 — Apr 2020 [monthly]

Completed PHASE1_PHASE2

▶ Show 5 earlier versions

Nov 2019 — Dec 2019 [monthly]

Completed PHASE1_PHASE2
Aug 2019 — Nov 2019 [monthly]

Completed PHASE1_PHASE2
Apr 2019 — Aug 2019 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Apr 2019 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States